ExCellThera
Montréal
About ExCellThera
ExCellThera is an advanced clinical stage biotechnology company delivering molecules and bioengineering solutions to expand blood stem and immune cells for therapeutic use. ExCellThera’s lead technology, ECT-001, combines a proprietary small molecule, UM171, and an optimized culture system. In pursuit of better treatments for patients, the company is building out its portfolio of products, as well as supporting best-in-class clinical trials.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $6.0M
- Last round: Grant (Feb 2020)
- Website: excellthera.com
Industries & Categories
Biotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/excellthera-124441 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.